A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema

NCT06305416 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema
Diabetic Retinopathy
Macular Edema
Macular Degeneration
Retinal Disease
Retinal Degeneration

Interventions

DRUG: Ranibizumab 10mg/ml Injection
DRUG: Lucentis

Sponsor

Incepta Pharmaceuticals Ltd

Collaborators

[object Object]